🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This novel fibrinolytic agent is a 136 amino acid single chain protein secr...
Status
Completed
Location
Sri Jayadeva Institute of Cardiology.
Start Date
2010-10
Trial ID
NCT01305226
Treatments Being Tested
Objective: to evaluate the efficacy and safety of intra-arterial intrathrom...
Status
Recruiting
Location
Kursk city emergency hospital
Start Date
2022-12-26
Trial ID
NCT05372718
Treatments Being Tested
The aim of the study is to determine if single-bolus recombinant nonimmunog...
Status
Completed
Location
Institute of Cardiology
Start Date
2014-05-16
Trial ID
NCT02301910
Treatments Being Tested
Multicenter, double-blind, randomized, placebo-controlled phase III clinica...
Status
Recruiting
Location
Ryazan Regional Clinical Hospital
Start Date
2026-06-09
Trial ID
NCT07324837
Treatments Being Tested
Objective: to evaluate the efficacy and safety of the Recombinant Non-immun...
Status
Completed
Location
V.F. Dolgopolov Vyselki Central District Hospital
Start Date
2020-12-15
Trial ID
NCT04688320
Treatments Being Tested
The aim of the study is to determine if single-bolus recombinant nonimmunog...
Status
Completed
Location
Regional Clinical Hospital
Start Date
2017-03-18
Trial ID
NCT03151993
Treatments Being Tested
This study was a prospective, multicenter, randomized, controlled, excellen...
Status
Completed
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2021-10-29
Trial ID
NCT05023681
Treatments Being Tested
As an effective treatment for acute ST-segment elevation myocardial infarct...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2023-04-08
Trial ID
NCT05410925
Treatments Being Tested
Objective: to evaluate the efficacy and safety of the non-immunogenic recom...
Status
Recruiting
Location
RZD Medicine hospital
Start Date
2024-05-23
Trial ID
NCT06362746
Treatments Being Tested
The OPTIMA-5 trial is a prospective, multi-center, randomized, patient blin...
Status
Completed
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2021-10-29
Trial ID
NCT05649696
Treatments Being Tested